CORE CONVERSATIONS
In this episode of Core Conversations, host Robbie Harmon is joined by Ampelis CEO Lon Henderson and content leader Kim Stoddard to unpack a thoughtful critique of their new whole-food supplement product, Core 7, written by a triple board-certified physician. Rather than reacting defensively, the team uses the critique as a launch point for a deeper conversation about skepticism in the supplement industry, the difference between pharmaceuticals and food-based interventions, the role of anecdotal evidence, and how intellectually honest disagreement can strengthen innovation. They acknowledge that the supplement industry has earned much of its skepticism due to overpromising, underdelivering, and prioritizing marketing over quality. Core 7, however, was not created as a profit-driven venture—but as a clinical solution after the team couldn’t find a product that met their standards for quality, dosing, breadth, and efficacy. The episode explores: * Why nutrition research often produces disagreement. * Why “certainty” is the wrong standard for nutritional products. * Why food-based interventions are both safer and more complex than pharmaceuticals. * The importance of transparency, humility, and long-term validation. * Why supplementation remains necessary even for people who “eat well.” The conversation ultimately reframes the debate: Core 7 isn’t meant to replace food or act like a pharmaceutical—it’s designed to close nutritional gaps and deliver functional, whole-food-based support for sleep, mood, energy, immunity, and cognitive performance in a simplified, accessible way.
17 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y únete a la comunidad de CORE CONVERSATIONS!